Integrated Filing — IndAS



General information about company
Scrip Code 523207
NSE Symbol KOKUYOCMLN
MSEI Symbol NA
ISIN INE760A01029
Name of company KOKUYO CAMLIN LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-Apr-2024
Date of end of financial year 31-Mar-2025
Date of board meeting when results were approved 28-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 20-May-2025
Description of presentation currency INR (in Actuals)
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Single segment
Description of single segment Consumer Products
Start date and time of board meeting 28-May-2025   15:45:00
End date and time of board meeting 28-May-2025   19:40:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Statement on impact of audit qualification
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 2022-07-27
Indicate Company website link for updated RPT policy of the Company https://www.kokuyocamlin.com/policies
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
Not Applicable



Financial Results Ind-AS
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Income
Revenue from operations 2000336000 7625288000
Other income -483000 7486000
Total income 1999853000 7632774000
2 Expenses
(a) Cost of materials consumed 757554000 3067958000
(b) Purchases of stock-in-trade 538062000 1644704000
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade -55062000 198134000
(d) Employee benefit expense 257065000 984689000
(e) Finance costs 10131000 46108000
(f) Depreciation, depletion and amortisation expense 53431000 212081000
(f) Other Expenses
1 Other Expenses 370689000 1391618000
Total other expenses 370689000 1391618000
Total expenses 1931870000 7545292000
3 Total profit before exceptional items and tax 67983000 87482000
4 Exceptional items 0 0
5 Total profit before tax 67983000 87482000
6 Tax expense
7 Current tax 27839000 34827000
8 Deferred tax -3742000 -5675000
9 Total tax expenses 24097000 29152000
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0 0
11 Net Profit Loss for the period from continuing operations 43886000 58330000
12 Profit (loss) from discontinued operations before tax 0 0
13 Tax expense of discontinued operations 0 0
14 Net profit (loss) from discontinued operation after tax 0 0
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0 0
16 Total profit (loss) for period 43886000 58330000
17 Other comprehensive income net of taxes 35469000 53046000
18 Total Comprehensive Income for the period 79355000 111376000
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 100304000 100304000
Face value of equity share capital 1 1
27 Details of debt securities
22 Reserves excluding revaluation reserve 2924191000
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 0.44 0.58
Diluted earnings (loss) per share from continuing operations 0.44 0.58
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 0.44 0.58
Diluted earnings (loss) per share from continuing and discontinued operations 0.44 0.58
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results
Textual Information(1) Notes: tttttt n 1 tThe above results have been reviewed by the Audit Committee and approved by the Board of Directors at their meeting held on 28 May 2025. The statutory auditors have performed an audit of the above results and issued a modified opinion thereon. This Statement has been prepared in accordance with Indian Accounting Standards notified under the Companies (Indian Accounting Standards) Rules, 2015 notified under section 133 of the Companies Act, 2013 and in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended from time to time).t n 2 tFigures for the quarter ended 31 March 2025 and the corresponding quarter ended in the previous year as reported in these financial results are the balancing figures between audited figures in respect of full financial year and the published year to date figures upto the end of the third quarter of the financial year. Also the figures upto the end of the third quarter had only been reviewed and not subjected to audit.t n 3 tOther income for the previous year ended 31 March 2024 includes profit on sale of Taloja plant of Rs. 459.19 lakhs.t n 4 tThe entire operations of the Company constitute a single operating segment i.e. Consumer Products as per Ind AS 108 Operating segments specified under section 133 of the Companies Act, 2013.t n 5 tThe Company has no Subsidiary, Associate or Joint Venture Company, as on 31 March 2025. n 6 tForeign exchange gain or loss is included under the following items in the above resultst ntParticularsttThree months endedt ttYear ended t nttt31.03.2025t31.12.2024t31.03.2024t31.03.2025t31.03.2024tOther incomet t 26.51 t 17.90 t 16.03 tOther expenset 18.24 t t t 6.33 t t n 7 tDuring the year ended 31 March 2025, the management, following an internal assessment, suo moto, had identified discrepancies between physical quantity recorded in the books of account and the physical inventory. The loss of Rs. 2,356.81 lakhs has been recognised during the year as Rs. 819.92 lakhs in cost of material consumed, Rs. 1,324.37 lakhs in changes in inventories and Rs. 212.52 lakhs towards indirect taxes. nThe Company engaged an independent external agency on 7 November 2024 to conduct a forensic audit for the period April 2021 to September 2024 at one of its plants to investigate the discrepancies. The report of the said agency dated 11 February 2025 is available on the website of the Stock Exchange along with management comments. Following the findings of the forensic investigation, management has undertaken appropriate disciplinary actions, including the termination of certain employees implicated in the matter. nConsidering the nature of the discrepancies identified in the report, no adjustment is made for the comparative periods in the financial results as the impact is not precisely ascertainable.t n n



Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities
Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2024
Date of end of reporting period 31-Mar-2025
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 1270961000
Capital work-in-progress
Investment property 273000
Goodwill 0
Other intangible assets 320370000
Intangible assets under development
Biological assets other than bearer plants
Investments accounted for using equity method
Non-current financial assets
Non-current investments 162560000
Trade receivables, non-current
Loans, non-current 0
Other non-current financial assets 30798000
Total non-current financial assets 193358000
Deferred tax assets (net)
Other non-current assets 130857000
Total non-current assets 1915819000
2 Current assets
Inventories 1503209000
Current financial asset
Current investments 0
Trade receivables, current 760066000
Cash and cash equivalents 72419000
Bank balance other than cash and cash equivalents 5023000
Loans, current 0
Other current financial assets
Total current financial assets 837508000
Current tax assets (net)
Other current assets 293269000
Total current assets 2633986000
3 Non-current assets classified as held for sale 0
4 Regulatory deferral account debit balances and related deferred tax Assets 0
Total assets 4549805000
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 100304000
Other equity 2924191000
Total equity attributable to owners of parent 3024495000
Non controlling interest
Total equity 3024495000
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 0
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises
Total Trade payable
Other non-current financial liabilities 104046000
Total non-current financial liabilities 104046000
Provisions, non-current 67052000
Deferred tax liabilities (net) 14125000
Deferred government grants, Non-current
Other non-current liabilities
Total non-current liabilities 185223000
Current liabilities
Current financial liabilities
Borrowings, current 411107000
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 37461000
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 489854000
Total Trade payable 527315000
Other current financial liabilities 273797000
Total current financial liabilities 1212219000
Other current liabilities 110914000
Provisions, current 16954000
Current tax liabilities (Net)
Deferred government grants, Current
Total current liabilities 1340087000
3 Liabilities directly associated with assets in disposal group classified as held for sale
4 Regulatory deferral account credit balances and related deferred tax liability
Total liabilities 1525310000
Total equity and liabilites 4549805000
Disclosure of notes on assets and liabilities



Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Jan-2025 01-Apr-2024
Date of end of reporting period 31-Mar-2025 31-Mar-2025
Whether accounts are audited or unaudited Audited Audited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Remeasurement of net defined benefit plan 118000 -15242000
2 Fair value changes of equity instruments through other comprehensive income 30193000 64218000
Total Amount of items that will not be reclassified to profit and loss 30311000 48976000
2 Income tax relating to items that will not be reclassified to profit or loss -5158000 -4070000
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss 0 0
5 Total Other comprehensive income 35469000 53046000



Cash flow statement, indirect
Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-Apr-2024
B Date of end of reporting period 31-Mar-2025
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
Part I Blue color marked fields are non-mandatory.
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 87482000
Adjustments for reconcile profit (loss)
Adjustments for finance costs 46108000
Adjustments for decrease (increase) in inventories 403511000
Adjustments for decrease (increase) in trade receivables, current 66618000
Adjustments for decrease (increase) in trade receivables, non-current 0
Adjustments for decrease (increase) in other current assets -26681000
Adjustments for decrease (increase) in other non-current assets 0
Adjustments for other financial assets, non-current 0
Adjustments for other financial assets, current 0
Adjustments for other bank balances 0
Adjustments for increase (decrease) in trade payables, current -136191000
Adjustments for increase (decrease) in trade payables, non-current 0
Adjustments for increase (decrease) in other current liabilities -16698000
Adjustments for increase (decrease) in other non-current liabilities 0
Adjustments for depreciation and amortisation expense 212081000
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0
Adjustments for provisions, current -6641000
Adjustments for provisions, non-current 0
Adjustments for other financial liabilities, current 0
Adjustments for other financial liabilities, non-current 0
Adjustments for unrealised foreign exchange losses gains 718000
Adjustments for dividend income 0
Adjustments for interest income 2228000
Adjustments for share-based payments 0
Adjustments for fair value losses (gains) 0
Adjustments for undistributed profits of associates 0
Other adjustments for which cash effects are investing or financing cash flow 0
Other adjustments to reconcile profit (loss) 288000
Other adjustments for non-cash items 0
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0
Total adjustments for reconcile profit (loss) 540885000
Net cash flows from (used in) operations 628367000
Dividends received 0
Interest paid 0
Interest received 0
Income taxes paid (refund) 83012000
Other inflows (outflows) of cash 0
Net cash flows from (used in) operating activities 545355000
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0
Cash flows used in obtaining control of subsidiaries or other businesses 0
Other cash receipts from sales of equity or debt instruments of other entities 0
Other cash payments to acquire equity or debt instruments of other entities 0
Other cash receipts from sales of interests in joint ventures 0
Other cash payments to acquire interests in joint ventures 0
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0
Proceeds from sales of property, plant and equipment 2588000
Purchase of property, plant and equipment 210655000
Proceeds from sales of investment property 0
Purchase of investment property 0
Proceeds from sales of intangible assets 0
Purchase of intangible assets 0
Proceeds from sales of intangible assets under development 0
Purchase of intangible assets under development 0
Proceeds from sales of goodwill 0
Purchase of goodwill 0
Proceeds from biological assets other than bearer plants 0
Purchase of biological assets other than bearer plants 0
Proceeds from government grants 0
Proceeds from sales of other long-term assets 0
Purchase of other long-term assets 0
Cash advances and loans made to other parties 0
Cash receipts from repayment of advances and loans made to other parties 0
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0
Dividends received 0
Interest received 736000
Income taxes paid (refund) 0
Other inflows (outflows) of cash -1943000
Net cash flows from (used in) investing activities -209274000
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0
Payments from changes in ownership interests in subsidiaries 0
Proceeds from issuing shares 0
Proceeds from issuing other equity instruments 0
Payments to acquire or redeem entity's shares 0
Payments of other equity instruments 0
Proceeds from exercise of stock options 0
Proceeds from issuing debentures notes bonds etc 0
Proceeds from borrowings -242055000
Repayments of borrowings 0
Payments of lease liabilities 22640000
Dividends paid 50152000
Interest paid 43394000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 0
Net cash flows from (used in) financing activities -358241000
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes -22160000
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0
Net increase (decrease) in cash and cash equivalents -22160000
Cash and cash equivalents cash flow statement at beginning of period 94579000
Cash and cash equivalents cash flow statement at end of period 72419000





Details of Impact of Audit Qualification
Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Statement on impact of audit qualification
Auditor's opinion Qualified opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 BSR and Co. LLP Yes 31-Jul-2025


Financial details
Sr. Particulars Audited Figures (as reported before adjusting for qualifications) Adjusted Figures (audited figures after adjusting for qualifications)
1 Turnover / Total income 7632774000 7632774000
2 Total Expenditure 7545292000 7545292000
3 Net Profit/(Loss) 58330000 58330000
4 Earnings Per Share 0.58 0.58
5 Total Assets 4549805000 4549805000
6 Total Liabilities 1525310000 1525310000
7 Net Worth 3024495000 3024495000


Audit qualification
Sr. Details of Audit Qualification Type of Audit Qualification Frequency of qualification For Audit Qualification(s) where the impact is quantified by the auditor For Audit Qualification(s) where the impact is not quantified by the auditor
Management's Views (i) Management's estimation on the impact of audit qualification (ii) If management is unable to estimate the impact, reasons for the same Auditors' Comments on (i) or (ii) above
1 Textual Information(1) Qualified opinion Whether appeared first time Textual Information(2) Textual Information(3) Textual Information(4) Textual Information(5)


Text Block
Textual Information(1) During the year, the management had identified discrepancies between physical quantity recorded in the books of account and the physical inventory. Accordingly, an expense (including indirect taxes) of Rs. 2,356.81 lakhs has been recognised for the year ended 31 March 2025. Management has not identified the possible impact, if any, of the discrepancy on the prior periods presented or opening balances as at 1 April 2023. As a result, no adjustment is made to the comparative information. This constitutes a departure from Indian Accounting Standard prescribed under section 133 of the Companies Act, 2013 (the Act) which requires correction of material prior period errors retrospectively.
Textual Information(2) Not Applicable n
Textual Information(3) Not quatifiable
Textual Information(4) Given the nature of the identified discrepancies in the forensic report, the management has concluded not to reinstate the financial statements of earlier years, as the impact is not precisely ascertainable.
Textual Information(5) none


Signatories detail
Name of CEO / Managing director Satish Veerappa
Name of CFO Nilesh Choudhary
Name of audit committee chairman Nandini Chopra
Name of statutory auditor Maulik Jhaveri
Name of other signatory, if any, with designation
Place Mumbai
Date 28-May-2025


Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)
Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 Kokuyo Camlin Limited Kokuyo Co. Ltd. Holding Company Purchase of goods or services Omnibus approval 4042000 264000 3482000
2 Kokuyo Camlin Limited Kokuyo Co. Ltd. Holding Company Sale of goods or services Omnibus approval 51757000 15130000 28657000
3 Kokuyo Camlin Limited Excella Pencils Pvt. Ltd. Mr. Dilip Dandekar, Non-Executive Director has indirect holding Purchase of goods or services Omnibus approval 59074000 0 0
4 Kokuyo Camlin Limited Kokuyo Vietnam Trading Co. Ltd. Fellow Subsidiary Company Purchase of goods or services Omnibus approval 49000 0 0
5 Kokuyo Camlin Limited Kokuyo Vietnam Trading Co. Ltd. Fellow Subsidiary Company Sale of goods or services Omnibus approval 137000 211000 137000
6 Kokuyo Camlin Limited Kokuyo Vietnam Co. Ltd. Fellow Subsidiary Company Purchase of goods or services Omnibus approval 560000 0 0
7 Kokuyo Camlin Limited Kokuyo Commerce Shanghai Co. Ltd. Fellow Subsidiary Company Sale of goods or services Omnibus approval 2267000 0 2266000
8 Kokuyo Camlin Limited Kokuyo International Malasiya SDN BHD Fellow Subsidiary Company Purchase of fixed assets Approved 1520000 0 0
9 Kokuyo Camlin Limited Mr. Dilip Dandekar Chairman & Non-Executive Director Remuneration Approved 1082000 0 0
10 Kokuyo Camlin Limited Mr. Shriram Dandekar Vice Chairman & Executive Director Remuneration Approved 9173000 0 0
11 Kokuyo Camlin Limited Mr. Satish Veerappa Managing Director Remuneration Approved 18054000 0 0
12 Kokuyo Camlin Limited Mr. Takeo Iguchi Executive Director Remuneration Approved 4591000 0 0
13 Kokuyo Camlin Limited Mr. Nilesh kumar Choudhary Chief Financial Officer Remuneration Approved 5071000 0 0
14 Kokuyo Camlin Limited Mr. Vipul Bhoy Company Secretary & Compliance Officer Remuneration Approved 1009000 0 0
15 Kokuyo Camlin Limited Ms. Nandini Chopra Non Executive Independent Director Remuneration Approved 540000 0 0
16 Kokuyo Camlin Limited Ms. Naho Shigeta Non Executive Independent Director Remuneration Approved 480000 0 0
17 Kokuyo Camlin Limited Mr. Nilesh Modi Non Executive Independent Director Remuneration Approved 380000 0 0
18 Kokuyo Camlin Limited Mr. Naganath Iyer Non Executive Independent Director Remuneration Approved 480000 0 0
19 Kokuyo Camlin Limited Mr. Tomoya Okada Non Executive Independent Director Remuneration Approved 540000 0 0
20 Kokuyo Camlin Limited Mr. Rahul Dandekar Relative of Director Remuneration Approved 1587000 0 0
21 Kokuyo Camlin Limited Ms. Aditi Dighe Relative of Director Remuneration Approved 1582000 0 0
22 Kokuyo Camlin Limited Kokuyo Co. Ltd. Holding Company Any other transaction Reimbursement of expenses received Approved 2336000 0 0
23 Kokuyo Camlin Limited Kokuyo Co. Ltd. Holding Company Any other transaction Reimbursement of expenses paid Approved 1700000 0 0
24 Kokuyo Camlin Limited Excella Pencils Pvt. Ltd. Mr. Dilip Dandekar, Non-Executive Director has indirect holding Any other transaction Reimbursement of expenses paid Approved 1120000 1029000 1582000
Total value of transaction during the reporting period 169131000